Blood derivatives maker Imuna has begun production again following its purchase last year in a bankruptcy tender by investor Pharm Holding.
Compiled by Tom Nicholson from press reports.
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
